Is chronic obstructive pulmonary disease an independent risk factor for transfusion in coronary artery bypass graft

Lacey M Stelle1, Theresa M Boley, Stephen J Markwell

  • 1Southern Illinois University School of Medicine, Springfield, IL, USA.

Insights

Chronic obstructive pulmonary disease (COPD) does not increase the risk of blood transfusion during coronary artery bypass graft (CABG) surgery. Objective pulmonary function tests confirm that even severe COPD does not predict transfusion needs in CABG patients.

Area of Science:

  • Cardiology
  • Pulmonology
  • Anesthesiology

Background:

  • The association between chronic obstructive pulmonary disease (COPD) and blood product transfusion during coronary artery bypass graft (CABG) surgery is debated.
  • Previous studies lack objective criteria for defining COPD, leading to inconsistent findings.

Purpose of the Study:

  • To investigate the role of COPD, defined by objective pulmonary function test (PFT) data, as a risk factor for blood transfusion in CABG patients.
  • To clarify conflicting literature regarding COPD and transfusion requirements in CABG.

Main Methods:

  • 180 patients undergoing primary, isolated, non-emergent CABG with preoperative PFTs were analyzed.
  • COPD was defined using FEV1/FVC <70% and stratified by GOLD guidelines.
  • Patients with and without COPD were compared for preoperative/postoperative characteristics and transfusion rates.

Main Results:

  • The overall transfusion rate was 59.4%.
  • COPD patients were older, had lower BMI, and were more often smokers, but had shorter cardiopulmonary bypass times.
  • Transfusion rates were similar between COPD and non-COPD groups, irrespective of COPD severity.

Conclusions:

  • Objective PFT data demonstrate that COPD is not a significant risk factor for blood transfusion during CABG.
  • Pulmonary function, even in severe COPD, does not predict the need for transfusion in this patient population.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...